APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Omeprazole Enteric-coated Capsules

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Omeprazole Enteric-coated Capsules Market Outlook and Growth Opportunities 2026

Report ID 174018820430 December 2025194 pages

Choose your research edition.

Industry ResearchOmeprazole Enteric-coated Capsules Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Omeprazole Enteric-coated Capsules Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Omeprazole Enteric-coated Capsules Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Omeprazole Enteric-coated Capsules Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Omeprazole Enteric-coated Capsules Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Omeprazole Enteric-coated Capsules market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Omeprazole Enteric-coated Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Omeprazole Enteric-coated Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Omeprazole Enteric-coated Capsules is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Omeprazole Enteric-coated Capsules market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Omeprazole Enteric-coated Capsules market include Shanghai Tianlong Pharmaceutical Co., Ltd., Shanxi Jinhuahuixing Pharmaceutical Co., Ltd., Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory, Ningbo Shuangwei Pharmaceutical Co., Ltd., Jiangsu Lianhuan Pharmaceutical Co., Ltd., Hainan Pioneer Pharmaceutical Co., Ltd., Hainan Hailing Pharmaceutical Factory Co., Ltd., Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. and Chengdu Tiantai Mount Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Omeprazole Enteric-coated Capsules market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Omeprazole Enteric-coated Capsules and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Omeprazole Enteric-coated Capsules sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Omeprazole Enteric-coated Capsules market size, projected growth trends, production technologies, key applications, and end-use industries.

Omeprazole Enteric-coated Capsules Segment by Company

Shanghai Tianlong Pharmaceutical Co., Ltd.

Shanxi Jinhuahuixing Pharmaceutical Co., Ltd.

Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory

Ningbo Shuangwei Pharmaceutical Co., Ltd.

Jiangsu Lianhuan Pharmaceutical Co., Ltd.

Hainan Pioneer Pharmaceutical Co., Ltd.

Hainan Hailing Pharmaceutical Factory Co., Ltd.

Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd.

Chengdu Tiantai Mount Pharmaceutical

AstraZeneca Pharmaceuticals Ltd.

Omeprazole Enteric-coated Capsules Segment by Type

10mg/piece

20mg/piece

Omeprazole Enteric-coated Capsules Segment by Application

Hospital Pharmacy

Retail Pharmacy

Others

Omeprazole Enteric-coated Capsules Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Omeprazole Enteric-coated Capsules status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Omeprazole Enteric-coated Capsules market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Omeprazole Enteric-coated Capsules significant trends, drivers, influence factors in global and regions.

6. To analyze Omeprazole Enteric-coated Capsules competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Omeprazole Enteric-coated Capsules market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Omeprazole Enteric-coated Capsules and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Omeprazole Enteric-coated Capsules.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Omeprazole Enteric-coated Capsules market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Omeprazole Enteric-coated Capsules industry.

Chapter 3: Detailed analysis of Omeprazole Enteric-coated Capsules manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Omeprazole Enteric-coated Capsules in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Omeprazole Enteric-coated Capsules in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Omeprazole Enteric-coated Capsules Industry Trends Table 2. Omeprazole Enteric-coated Capsules Industry Drivers Table 3. Omeprazole Enteric-coated Capsules Industry Opportunities and Challenges Table 4. Omeprazole Enteric-coated Capsules Industry Restraints Table 5. Global Omeprazole Enteric-coated Capsules Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Omeprazole Enteric-coated Capsules Revenue Share by Company (2021-2026) Table 7. Global Omeprazole Enteric-coated Capsules Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Company (2021-2026) Table 9. Global Omeprazole Enteric-coated Capsules Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Omeprazole Enteric-coated Capsules Company Ranking, (2024-2026) & (USD Million) Table 11. Global Omeprazole Enteric-coated Capsules Key Company Manufacturing Base & Headquarters Table 12. Global Omeprazole Enteric-coated Capsules Company, Product Type & Application Table 13. Global Omeprazole Enteric-coated Capsules Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Omeprazole Enteric-coated Capsules by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of 10mg/piece Table 18. Significant Companies of 20mg/piece Table 19. Global Omeprazole Enteric-coated Capsules Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Omeprazole Enteric-coated Capsules Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Omeprazole Enteric-coated Capsules Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Type (2021-2026) Table 23. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Type (2027-2032) Table 24. Global Omeprazole Enteric-coated Capsules Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Omeprazole Enteric-coated Capsules Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Omeprazole Enteric-coated Capsules Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Omeprazole Enteric-coated Capsules Sales Value Share by Type (2021-2026) Table 28. Global Omeprazole Enteric-coated Capsules Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Hospital Pharmacy Table 30. Significant Companies of Retail Pharmacy Table 31. Significant Companies of Others Table 32. Global Omeprazole Enteric-coated Capsules Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Omeprazole Enteric-coated Capsules Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Omeprazole Enteric-coated Capsules Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Application (2021-2026) Table 36. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Application (2027-2032) Table 37. Global Omeprazole Enteric-coated Capsules Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Omeprazole Enteric-coated Capsules Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Omeprazole Enteric-coated Capsules Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Omeprazole Enteric-coated Capsules Sales Value Share by Application (2021-2026) Table 41. Global Omeprazole Enteric-coated Capsules Sales Value Share by Application (2027-2032) Table 42. Global Omeprazole Enteric-coated Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Omeprazole Enteric-coated Capsules Sales by Region (2021-2026) & (K Units) Table 44. Global Omeprazole Enteric-coated Capsules Sales Market Share by Region (2021-2026) Table 45. Global Omeprazole Enteric-coated Capsules Sales by Region (2027-2032) & (K Units) Table 46. Global Omeprazole Enteric-coated Capsules Sales Market Share by Region (2027-2032) Table 47. Global Omeprazole Enteric-coated Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Omeprazole Enteric-coated Capsules Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Omeprazole Enteric-coated Capsules Sales Value Share by Region (2021-2026) Table 50. Global Omeprazole Enteric-coated Capsules Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Omeprazole Enteric-coated Capsules Sales Value Share by Region (2027-2032) Table 52. Global Omeprazole Enteric-coated Capsules Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Omeprazole Enteric-coated Capsules Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Omeprazole Enteric-coated Capsules Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Omeprazole Enteric-coated Capsules Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Omeprazole Enteric-coated Capsules Sales by Country (2021-2026) & (K Units) Table 57. Global Omeprazole Enteric-coated Capsules Sales Market Share by Country (2021-2026) Table 58. Global Omeprazole Enteric-coated Capsules Sales by Country (2027-2032) & (K Units) Table 59. Global Omeprazole Enteric-coated Capsules Sales Market Share by Country (2027-2032) Table 60. Global Omeprazole Enteric-coated Capsules Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Omeprazole Enteric-coated Capsules Sales Value Market Share by Country (2021-2026) Table 62. Global Omeprazole Enteric-coated Capsules Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Omeprazole Enteric-coated Capsules Sales Value Market Share by Country (2027-2032) Table 64. Shanghai Tianlong Pharmaceutical Co., Ltd. Company Information Table 65. Shanghai Tianlong Pharmaceutical Co., Ltd. Business Overview Table 66. Shanghai Tianlong Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Shanghai Tianlong Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 68. Shanghai Tianlong Pharmaceutical Co., Ltd. Recent Development Table 69. Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Company Information Table 70. Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Business Overview Table 71. Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 73. Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Recent Development Table 74. Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Company Information Table 75. Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Business Overview Table 76. Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Omeprazole Enteric-coated Capsules Product Portfolio Table 78. Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Recent Development Table 79. Ningbo Shuangwei Pharmaceutical Co., Ltd. Company Information Table 80. Ningbo Shuangwei Pharmaceutical Co., Ltd. Business Overview Table 81. Ningbo Shuangwei Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Ningbo Shuangwei Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 83. Ningbo Shuangwei Pharmaceutical Co., Ltd. Recent Development Table 84. Jiangsu Lianhuan Pharmaceutical Co., Ltd. Company Information Table 85. Jiangsu Lianhuan Pharmaceutical Co., Ltd. Business Overview Table 86. Jiangsu Lianhuan Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Jiangsu Lianhuan Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 88. Jiangsu Lianhuan Pharmaceutical Co., Ltd. Recent Development Table 89. Hainan Pioneer Pharmaceutical Co., Ltd. Company Information Table 90. Hainan Pioneer Pharmaceutical Co., Ltd. Business Overview Table 91. Hainan Pioneer Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 92. Hainan Pioneer Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 93. Hainan Pioneer Pharmaceutical Co., Ltd. Recent Development Table 94. Hainan Hailing Pharmaceutical Factory Co., Ltd. Company Information Table 95. Hainan Hailing Pharmaceutical Factory Co., Ltd. Business Overview Table 96. Hainan Hailing Pharmaceutical Factory Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 97. Hainan Hailing Pharmaceutical Factory Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 98. Hainan Hailing Pharmaceutical Factory Co., Ltd. Recent Development Table 99. Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Company Information Table 100. Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Business Overview Table 101. Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 102. Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 103. Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Recent Development Table 104. Chengdu Tiantai Mount Pharmaceutical Company Information Table 105. Chengdu Tiantai Mount Pharmaceutical Business Overview Table 106. Chengdu Tiantai Mount Pharmaceutical Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 107. Chengdu Tiantai Mount Pharmaceutical Omeprazole Enteric-coated Capsules Product Portfolio Table 108. Chengdu Tiantai Mount Pharmaceutical Recent Development Table 109. AstraZeneca Pharmaceuticals Ltd. Company Information Table 110. AstraZeneca Pharmaceuticals Ltd. Business Overview Table 111. AstraZeneca Pharmaceuticals Ltd. Omeprazole Enteric-coated Capsules Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 112. AstraZeneca Pharmaceuticals Ltd. Omeprazole Enteric-coated Capsules Product Portfolio Table 113. AstraZeneca Pharmaceuticals Ltd. Recent Development Table 114. Key Raw Materials Table 115. Raw Materials Key Suppliers Table 116. Omeprazole Enteric-coated Capsules Distributors List Table 117. Omeprazole Enteric-coated Capsules Customers List Table 118. Research Programs/Design for This Report Table 119. Authors List of This Report Table 120. Secondary Sources Table 121. Primary Sources List of Figures Figure 1. Omeprazole Enteric-coated Capsules Product Image Figure 2. Global Omeprazole Enteric-coated Capsules Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Omeprazole Enteric-coated Capsules Sales Value (2021-2032) & (US$ Million) Figure 4. Global Omeprazole Enteric-coated Capsules Sales (2021-2032) & (K Units) Figure 5. Global Omeprazole Enteric-coated Capsules Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Omeprazole Enteric-coated Capsules Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. 10mg/piece Image Figure 10. 20mg/piece Image Figure 11. Global Omeprazole Enteric-coated Capsules Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Omeprazole Enteric-coated Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Type (2021-2032) Figure 14. Global Omeprazole Enteric-coated Capsules Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Omeprazole Enteric-coated Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Omeprazole Enteric-coated Capsules Sales Value Share by Type (2021-2032) Figure 17. Hospital Pharmacy Image Figure 18. Retail Pharmacy Image Figure 19. Others Image Figure 20. Global Omeprazole Enteric-coated Capsules Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Omeprazole Enteric-coated Capsules Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Omeprazole Enteric-coated Capsules Sales Volume Share by Application (2021-2032) Figure 23. Global Omeprazole Enteric-coated Capsules Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Omeprazole Enteric-coated Capsules Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Omeprazole Enteric-coated Capsules Sales Value Share by Application (2021-2032) Figure 26. Global Omeprazole Enteric-coated Capsules Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Omeprazole Enteric-coated Capsules Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Omeprazole Enteric-coated Capsules Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Omeprazole Enteric-coated Capsules Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Omeprazole Enteric-coated Capsules Sales Value (2021-2032) & (US$ Million) Figure 31. North America Omeprazole Enteric-coated Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Omeprazole Enteric-coated Capsules Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Omeprazole Enteric-coated Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Omeprazole Enteric-coated Capsules Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Omeprazole Enteric-coated Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Omeprazole Enteric-coated Capsules Sales Value (2021-2032) & (US$ Million) Figure 37. South America Omeprazole Enteric-coated Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Omeprazole Enteric-coated Capsules Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Omeprazole Enteric-coated Capsules Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Omeprazole Enteric-coated Capsules Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Omeprazole Enteric-coated Capsules Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • 10mg/piece
  • 20mg/piece
Applications
  • Hospital Pharmacy
  • Retail Pharmacy
  • Others
Companies covered
  • Shanghai Tianlong Pharmaceutical Co., Ltd.
  • Shanxi Jinhuahuixing Pharmaceutical Co., Ltd.
  • Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory
  • Ningbo Shuangwei Pharmaceutical Co., Ltd.
  • Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  • Hainan Pioneer Pharmaceutical Co., Ltd.
  • Hainan Hailing Pharmaceutical Factory Co., Ltd.
  • Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd.
  • Chengdu Tiantai Mount Pharmaceutical
  • AstraZeneca Pharmaceuticals Ltd.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Omeprazole Enteric-coated Capsules Sales Value (2021-2032)
  4. 1.2.2 Global Omeprazole Enteric-coated Capsules Sales Volume (2021-2032)
  5. 1.2.3 Global Omeprazole Enteric-coated Capsules Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Omeprazole Enteric-coated Capsules Market Dynamics
  1. 2.1 Omeprazole Enteric-coated Capsules Industry Trends
  2. 2.2 Omeprazole Enteric-coated Capsules Industry Drivers
  3. 2.3 Omeprazole Enteric-coated Capsules Industry Opportunities and Challenges
  4. 2.4 Omeprazole Enteric-coated Capsules Industry Restraints
3 Omeprazole Enteric-coated Capsules Market by Company
  1. 3.1 Global Omeprazole Enteric-coated Capsules Company Revenue Ranking in 2025
  2. 3.2 Global Omeprazole Enteric-coated Capsules Revenue by Company (2021-2026)
  3. 3.3 Global Omeprazole Enteric-coated Capsules Sales Volume by Company (2021-2026)
  4. 3.4 Global Omeprazole Enteric-coated Capsules Average Price by Company (2021-2026)
  5. 3.5 Global Omeprazole Enteric-coated Capsules Company Ranking (2024-2026)
  6. 3.6 Global Omeprazole Enteric-coated Capsules Company Manufacturing Base and Headquarters
  7. 3.7 Global Omeprazole Enteric-coated Capsules Company Product Type and Application
  8. 3.8 Global Omeprazole Enteric-coated Capsules Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Omeprazole Enteric-coated Capsules Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Omeprazole Enteric-coated Capsules Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Omeprazole Enteric-coated Capsules Market by Type
  1. 4.1 Omeprazole Enteric-coated Capsules Type Introduction
  2. 4.1.1 10mg/piece
  3. 4.1.2 20mg/piece
  4. 4.2 Global Omeprazole Enteric-coated Capsules Sales Volume by Type
  5. 4.2.1 Global Omeprazole Enteric-coated Capsules Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Omeprazole Enteric-coated Capsules Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Omeprazole Enteric-coated Capsules Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Omeprazole Enteric-coated Capsules Sales Value by Type
  9. 4.3.1 Global Omeprazole Enteric-coated Capsules Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Omeprazole Enteric-coated Capsules Sales Value by Type (2021-2032)
  11. 4.3.3 Global Omeprazole Enteric-coated Capsules Sales Value Share by Type (2021-2032)
5 Omeprazole Enteric-coated Capsules Market by Application
  1. 5.1 Omeprazole Enteric-coated Capsules Application Introduction
  2. 5.1.1 Hospital Pharmacy
  3. 5.1.2 Retail Pharmacy
  4. 5.1.3 Others
  5. 5.2 Global Omeprazole Enteric-coated Capsules Sales Volume by Application
  6. 5.2.1 Global Omeprazole Enteric-coated Capsules Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Omeprazole Enteric-coated Capsules Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Omeprazole Enteric-coated Capsules Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Omeprazole Enteric-coated Capsules Sales Value by Application
  10. 5.3.1 Global Omeprazole Enteric-coated Capsules Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Omeprazole Enteric-coated Capsules Sales Value by Application (2021-2032)
  12. 5.3.3 Global Omeprazole Enteric-coated Capsules Sales Value Share by Application (2021-2032)
6 Omeprazole Enteric-coated Capsules Regional Sales and Value Analysis
  1. 6.1 Global Omeprazole Enteric-coated Capsules Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Omeprazole Enteric-coated Capsules Sales by Region (2021-2032)
  3. 6.2.1 Global Omeprazole Enteric-coated Capsules Sales by Region: 2021-2026
  4. 6.2.2 Global Omeprazole Enteric-coated Capsules Sales by Region (2027-2032)
  5. 6.3 Global Omeprazole Enteric-coated Capsules Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Omeprazole Enteric-coated Capsules Sales Value by Region (2021-2032)
  7. 6.4.1 Global Omeprazole Enteric-coated Capsules Sales Value by Region: 2021-2026
  8. 6.4.2 Global Omeprazole Enteric-coated Capsules Sales Value by Region (2027-2032)
  9. 6.5 Global Omeprazole Enteric-coated Capsules Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Omeprazole Enteric-coated Capsules Sales Value (2021-2032)
  12. 6.6.2 North America Omeprazole Enteric-coated Capsules Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Omeprazole Enteric-coated Capsules Sales Value (2021-2032)
  15. 6.7.2 Europe Omeprazole Enteric-coated Capsules Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Omeprazole Enteric-coated Capsules Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Omeprazole Enteric-coated Capsules Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Omeprazole Enteric-coated Capsules Sales Value (2021-2032)
  21. 6.9.2 South America Omeprazole Enteric-coated Capsules Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Omeprazole Enteric-coated Capsules Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Omeprazole Enteric-coated Capsules Sales Value Share by Country, 2025 VS 2032
7 Omeprazole Enteric-coated Capsules Country-level Sales and Value Analysis
  1. 7.1 Global Omeprazole Enteric-coated Capsules Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Omeprazole Enteric-coated Capsules Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Omeprazole Enteric-coated Capsules Sales by Country (2021-2032)
  4. 7.3.1 Global Omeprazole Enteric-coated Capsules Sales by Country (2021-2026)
  5. 7.3.2 Global Omeprazole Enteric-coated Capsules Sales by Country (2027-2032)
  6. 7.4 Global Omeprazole Enteric-coated Capsules Sales Value by Country (2021-2032)
  7. 7.4.1 Global Omeprazole Enteric-coated Capsules Sales Value by Country (2021-2026)
  8. 7.4.2 Global Omeprazole Enteric-coated Capsules Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Omeprazole Enteric-coated Capsules Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Omeprazole Enteric-coated Capsules Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Omeprazole Enteric-coated Capsules Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Shanghai Tianlong Pharmaceutical Co., Ltd.
  2. 8.1.1 Shanghai Tianlong Pharmaceutical Co., Ltd. Company Information
  3. 8.1.2 Shanghai Tianlong Pharmaceutical Co., Ltd. Business Overview
  4. 8.1.3 Shanghai Tianlong Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Shanghai Tianlong Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  6. 8.1.5 Shanghai Tianlong Pharmaceutical Co., Ltd. Recent Developments
  7. 8.2 Shanxi Jinhuahuixing Pharmaceutical Co., Ltd.
  8. 8.2.1 Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Company Information
  9. 8.2.2 Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Business Overview
  10. 8.2.3 Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  12. 8.2.5 Shanxi Jinhuahuixing Pharmaceutical Co., Ltd. Recent Developments
  13. 8.3 Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory
  14. 8.3.1 Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Company Information
  15. 8.3.2 Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Business Overview
  16. 8.3.3 Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Omeprazole Enteric-coated Capsules Product Portfolio
  18. 8.3.5 Shandong Wanjie High-tech Co., Ltd. Pharmaceutical Factory Recent Developments
  19. 8.4 Ningbo Shuangwei Pharmaceutical Co., Ltd.
  20. 8.4.1 Ningbo Shuangwei Pharmaceutical Co., Ltd. Company Information
  21. 8.4.2 Ningbo Shuangwei Pharmaceutical Co., Ltd. Business Overview
  22. 8.4.3 Ningbo Shuangwei Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Ningbo Shuangwei Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  24. 8.4.5 Ningbo Shuangwei Pharmaceutical Co., Ltd. Recent Developments
  25. 8.5 Jiangsu Lianhuan Pharmaceutical Co., Ltd.
  26. 8.5.1 Jiangsu Lianhuan Pharmaceutical Co., Ltd. Company Information
  27. 8.5.2 Jiangsu Lianhuan Pharmaceutical Co., Ltd. Business Overview
  28. 8.5.3 Jiangsu Lianhuan Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Jiangsu Lianhuan Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  30. 8.5.5 Jiangsu Lianhuan Pharmaceutical Co., Ltd. Recent Developments
  31. 8.6 Hainan Pioneer Pharmaceutical Co., Ltd.
  32. 8.6.1 Hainan Pioneer Pharmaceutical Co., Ltd. Company Information
  33. 8.6.2 Hainan Pioneer Pharmaceutical Co., Ltd. Business Overview
  34. 8.6.3 Hainan Pioneer Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Hainan Pioneer Pharmaceutical Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  36. 8.6.5 Hainan Pioneer Pharmaceutical Co., Ltd. Recent Developments
  37. 8.7 Hainan Hailing Pharmaceutical Factory Co., Ltd.
  38. 8.7.1 Hainan Hailing Pharmaceutical Factory Co., Ltd. Company Information
  39. 8.7.2 Hainan Hailing Pharmaceutical Factory Co., Ltd. Business Overview
  40. 8.7.3 Hainan Hailing Pharmaceutical Factory Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Hainan Hailing Pharmaceutical Factory Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  42. 8.7.5 Hainan Hailing Pharmaceutical Factory Co., Ltd. Recent Developments
  43. 8.8 Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd.
  44. 8.8.1 Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Company Information
  45. 8.8.2 Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Business Overview
  46. 8.8.3 Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  48. 8.8.5 Harbin Pharmaceutical Group Sanjing Pharmaceutical Nuojie Co., Ltd. Recent Developments
  49. 8.9 Chengdu Tiantai Mount Pharmaceutical
  50. 8.9.1 Chengdu Tiantai Mount Pharmaceutical Company Information
  51. 8.9.2 Chengdu Tiantai Mount Pharmaceutical Business Overview
  52. 8.9.3 Chengdu Tiantai Mount Pharmaceutical Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Chengdu Tiantai Mount Pharmaceutical Omeprazole Enteric-coated Capsules Product Portfolio
  54. 8.9.5 Chengdu Tiantai Mount Pharmaceutical Recent Developments
  55. 8.10 AstraZeneca Pharmaceuticals Ltd.
  56. 8.10.1 AstraZeneca Pharmaceuticals Ltd. Company Information
  57. 8.10.2 AstraZeneca Pharmaceuticals Ltd. Business Overview
  58. 8.10.3 AstraZeneca Pharmaceuticals Ltd. Omeprazole Enteric-coated Capsules Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 AstraZeneca Pharmaceuticals Ltd. Omeprazole Enteric-coated Capsules Product Portfolio
  60. 8.10.5 AstraZeneca Pharmaceuticals Ltd. Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Omeprazole Enteric-coated Capsules Value Chain Analysis
  2. 9.1.1 Omeprazole Enteric-coated Capsules Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Omeprazole Enteric-coated Capsules Sales Mode & Process
  6. 9.2 Omeprazole Enteric-coated Capsules Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Omeprazole Enteric-coated Capsules Distributors
  9. 9.2.3 Omeprazole Enteric-coated Capsules Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst